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Background: The purpose of this research is to evaluate the effects of a tourniquet in total knee arthroplasty (TKA).
Methods: The study was done by randomized controlled trials (RCTs) on the effects of a tourniquet in TKA. All
related articles which were published up to June 2013 from Medline, Embase, and Cochrane Central Register of
Controlled Trails were identified. The methodological quality of the included studies was assessed by the
Physiotherapy Evidence Database (PEDro) scale. The meta-analysis was performed using Cochrane RevMan software
version 5.1.
Results: Thirteen RCTs that involved a total of 689 patients with 689 knees were included in the meta-analysis,
which were divided into two groups. The tourniquet group included 351 knees and the non-tourniquet group
included 338 knees. The meta-analysis showed that using a tourniquet in TKA could reduce intraoperative blood
loss (weighted mean difference (WMD), −198.21; 95% confidence interval (CI), −279.82 to −116.60; P < 0.01) but did
not decrease the calculated blood loss (P = 0.80), which indicates the actual blood loss. Although TKA with a
tourniquet could save the operation time for 4.57 min compared to TKA without a tourniquet (WMD, −4.57;
95% CI, −7.59 to −1.56; P < 0.01), it had no clinical significance. Meanwhile, the use of tourniquet could not reduce
the possibility of blood transfusion (P > 0.05). Postoperative knee range of motion (ROM) in tourniquet group was
10.41° less than that in the non-tourniquet group in early stage (≤10 days after surgery) (WMD, −10.41;
95% CI, −16.41 to −4.41; P < 0.01). Moreover, the use of a tourniquet increased the risk of either thrombotic
events (risk ratio (RR), 5.00; 95% CI, 1.31 to 19.10; P = 0.02) or non-thrombotic complications (RR, 2.03; 95% CI,
1.12 to 3.67; P = 0.02).
Conclusions: TKA without a tourniquet was superior to TKA with a tourniquet in thromboembolic events and the
other related complications. There were no significant differences between the two groups in the actual blood loss.
TKA with a tourniquet might hinder patients' early postoperative rehabilitation exercises.
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Total knee arthroplasty (TKA) is commonly performed
using a tourniquet. A recent survey reported that 95% of
the members of the American Association of Hip and
Knee surgeons used a tourniquet for TKA [1]. Most
orthopedic surgeons believed that extensive soft tissue
release and bone cuts could result in higher blood loss
in TKA. However, the application of a tourniquet offered
better visualization of the structures and reduced intra-
operative blood loss, which theoretically would facilitate* Correspondence: lbchen@whu.edu.cn
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Furthermore, the tourniquet could help reduce the oper-
ation time. Yavarikia et al. reported that the use of a tour-
niquet in TKA resulted in a much shorter operation time
[3]. A prospective study by Willis-Owen et al. included
3,449 total knee arthroplasty showed that a prolonged op-
erating time was associated with an increased incidence of
infection [4].
However, some studies reported that several complica-
tions were associated with the use of a tourniquet in TKA,
including skin blistering, wound hematoma, wound ooze,
muscle injury, rhabdomyolysis, nerve palsy, postoperative
stiffness, deep vein thrombosis (DVT), and pulmonaryLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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interfere with the postoperative functional recovery and
could result in unnecessary discomfort for the patients.
There were some reports of severe and fatal complications
following TKA with a tourniquet, which included pul-
monary edema [11], renal failure [10], and PE that led to
death in some cases.
Several randomized controlled trials (RCTs) comparing
the effects of tourniquet use or not in TKA have been
published, but these studies had different endpoints.
Specially, TKA has become a standard operative pro-
cedure for relieving pain and restoring function [12],
and there is no published meta-analysis comparing the
use of a tourniquet and summarized statistical comparison
of postoperative function recovery. Therefore, it is neces-
sary to have a latest meta-analysis to summarize those is-
sues. This study reviews the effects of a tourniquet use in
TKA in order to provide an evidence for clear clinical
guidance.
Methods
The following criteria were required for inclusion: (1)
patients underwent unilateral primary TKA, (2) a RCT
comparing patients undergoing TKA with or without a
tourniquet, (3) patients suffering from primary osteo-
arthritis (OA) or rheumatoid arthritis (RA), and (4) full
text must be published in English.
The following criteria were required for exclusion: (1)
bilateral TKA, revision TKA, and complicated TKA; (2)
animal studies.
Electronic databases (Medline, Embase, and Cochrane
Central Register of Controlled Trails) were searched by
two independent researchers (ZW and CSF), which were
published up to June 2013. The key words used in the
search were ‘total knee arthroplasty’ or ‘total knee re-
placement’ and ‘tourniquet’ and ‘randomized controlled
trial’. Reference lists of the relevant papers were also
looked through for any further relevant studies.
The methodological quality of each included RCT
was assessed by two independent researchers (ZW and
CSF) by the Physiotherapy Evidence Database (PEDro)
scale [13]. Because the PEDro score demonstrated mod-
erate inter-rater reliability [intraclass correlation coef-
ficient = 0.68; (95% CI: 0.57–0.76)] for clinical trials [14].
A trial with a score of 6 or more was considered high
quality. All disagreements were resolved by the corre-
sponding author (CLB).
Two authors (ZW and CSF) extracted relevant data, in-
cluding sample size, study design, patient age, sex, body
mass index (BMI), operation time, the intraoperative
blood loss, overt blood loss, calculated blood loss, number
of transfusion, knee range of motion (ROM), thrombopro-
phylaxis, drainage system, thromboembolic events, and
the non-thrombotic complications.The meta-analysis was conducted with Cochrane
Collaboration Review Manager 5.1 software. For continu-
ous data, a weighted mean difference (WMD) and 95%
confidence interval (CI) was used. For dichotomous
outcomes, risk ratio/relative risk (RR) and 95% CI were
calculated as the summary statistics. The statistical hetero-
geneity was tested with the Chi-square test and I2. The
value of I2 < 25% was considered low statistical heterogen-
eity; I2 < 50%, moderate statistical heterogeneity; I2 < 75%,
high statistical heterogeneity [15].
Results
Study selection
A total of 343 articles were identified for the meta-
analysis. Of these, 321 studies were excluded because
the titles or abstracts did not meet the eligibility criteria.
Then, 22 papers were retrieved in full text. Five litera-
tures were not RCTs, and two trials included bilateral
TKA during the same surgery [16,17]. What is more,
two studies were excluded for some intervening mea-
sures with potential to influence the result [18,19]. For
one, in Kiss et al.'s study, the non-tourniquet group used
epinephrine-augmented hypotensive epidural anesthesia,
and the tourniquet group patients received normoten-
sive epidural anesthesia [18]. Epinephrine-augmented
hypotensive epidural anesthesia could affect the blood
loss [20], which might influence on other aspects of
patients. For other, in Padala et al.'s study, the non-
tourniquet group received 2.5 mg of adrenaline di-
luted in 500 ml of normal saline which was then in-
filtrated into the skin, subcutaneous tissues, and capsule
before surgical incision. However, the tourniquet group
did not receive it [19]. As a result, the aforemen-
tioned nine studies were excluded. Finally, 13 RCTs
comparing the effects of using a tourniquet or not in
TKA were included in the meta-analysis. A summary
of the review process was presented (Figure 1). All of
the papers were published in English. The dataset in-
cluded 689 patients (689 knees). The study included 351
TKAs with a tourniquet compared with 338 TKAs with-
out a tourniquet.
Critical appraisal
The methodological quality of each included RCTs was
assessed in accordance with the PEDro scale (Table 1).
The results showed that 11 RCTs were of high quality
and only 2 were of low quality. All trials used random-
ized method and six of them described the details of
randomized method. Six studies used concealed alloca-
tion. Eight studies used the blinding method.
Outcomes
The intraoperative blood loss was described in eight
studies, but two of them were excluded because the
Figure 1 Flow chart summarizing the selection process of randomized control trials (RCTs).
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by the anesthetists using their experience to estimate
how much blood loss was in the soaked sponges and
another research did not record blood loss in sponges
[30]. The pooling data showed that using a tourniquet in
TKA significantly decreased intraoperative blood loss by
198.21 ml (WMD, −198.21; 95% CI, −279.82 to −116.60;
P < 0.01) (Figure 2a).
Five papers described the postoperative visible blood
loss. They included soaked dressings blood and suc-
tion drains blood loss. The Forest plot of postoperative
visible blood loss showed no significant difference be-
tween TKA with a tourniquet and without a tourniquet
(WMD, −5.80; 95% CI, −176.25 to −164.64; P = 0.95)
(Figure 2b).
Five studies reported calculated blood loss. Because
high statistical heterogeneity existed among these studies
(P < 0.01; I2 = 85%), a subgroup analysis based on the cal-
culative timing of the calculated blood loss was done.Two trials calculated total blood loss from hemoglobin
and hematocrit values at 24th postoperative hour [23,24].
However, the other three studies calculated it from the
lowest hemoglobin and hematocrit levels on postoperative
day 4 or 7 [5,21,22]. Therefore, the five studies were di-
vided into these two subgroups. There were no significant
difference between TKA with a tourniquet and TKA with-
out a tourniquet (WMD, 63.20; 95% CI, −91.04 to 277.44;
P = 0.80) (Figure 2c).
Seven studies mentioned the incidence of transfusion.
Yet, one study was excluded for the reason that patients
had preoperative autologous donation of blood [30]. The
pooling result showed no statistical difference in ratio of
transfusion between the two groups (RR, 1.27; 95% CI,
0.66 to 2.43; P = 0.47) (Figure 2d).
Nine trials recorded the operation time. The operation
time in tourniquet group was 4.57 min less than non-
tourniquet group (WMD, −4.57; 95% CI, −7.59 to −1.56;
P < 0.01) (Figure 3).
Table 1 PEDro critical appraisal scores
Study PEDro critical appraisal scorea Total
1 2 3 4 5 6 7 8 9 10 11
Tai [21] Y Y Y Y Y N Y Y Y Y Y 9
Ledin [22] Y Y Y Y Y N N Y N Y Y 7
Zhang [23] Y Y N Y N N N Y Y Y Y 6
Li [24] Y Y N Y Y N N Y Y Y Y 7
Kageyama [25] Y Y Y Y Y N Y Y Y Y Y 9
Matziolis [26] Y Y N Y Y N N Y Y Y Y 8
Aglietti [27] Y Y N Y N N N Y Y Y Y 6
Tetro [5] Y Y Y Y Y N Y Y Y Y Y 9
Clarke [28] Y Y Y N Y N N Y N Y Y 6
Wauke [29] Y Y N N N N N Y Y Y Y 5
Vandenbussche [30] Y Y Y Y Y N N Y Y Y Y 8
Wakankar [31] Y Y N Y N N N Y Y Y Y 6
Abdel-Salam [32] Y Y N Y N N N Y N Y Y 5
aPEDro criteria: (1) eligibility criteria, (2) random allocation, (3) concealed
allocation, (4) baseline comparability, (5) participant blinding, (6) therapist
blinding, (7) assessor blinding, (8) >85% follow-up, (9) intention-to-treat
analysis, (10) between-groups statistical comparison for at least one key
outcome, (11) point estimates and variability measures for at least one key
outcome. N no, PEDro Physiotherapy Evidence Database scale, Y yes.
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gery) was reported in five studies. However, three studies
did not have standard deviation [22,31,32]. Therefore,
the meta-analysis was performed on the remaining two
studies. The pooling result showed postoperative ROM
in early stage of TKA with a tourniquet was 10.41° less
than that of TKA without a tourniquet (WMD, −10.41;
95% CI, −16.41 to −4.41; P < 0.01) (Figure 4).
Venous throboembolism (VTE) is the most common
complication following TKA. Manifesting as DVT or PE,
VTE is a leading cause of medical morbidity and mortality
[33]. Therefore, for the current analysis, we divided the
complications into two parts, namely, thrombotic events
and non-thrombotic complications. DVT and PE were in-
cluded in thrombotic events. Cases of thrombotic events
were reported in nine studies. The pooling data stated that
using a tourniquet in TKA significantly increased the risk
of thrombosis compared to TKA without a tourniquet (RR,
5.00; 95% CI, 1.31 to 19.10; P = 0.02) (Figure 5a). The inci-
dence of the non-thrombotic complications, (i.e., infection,
blister, hematoma, wound oozing, bruising, nerve palsy,
reoperation, etc.) showed statistical difference between
the two groups (RR, 2.03; 95% CI, 1.12 to 3.67; P= 0.02)
(Figure 5b). Therefore, the result of the current meta-
analysis indicated that TKA performed using a tourniquet
could increase the incidence of postoperative complications.
Discussion
The most significant finding of this study was that TKA with
a tourniquet could increase postoperative complications. Inaddition, using a tourniquet in TKA could not reduce the
total blood loss, although it could decrease the intraopera-
tive blood loss. At the same time, postoperative ROM in
tourniquet group was less than that in non-tourniquet
group in the early stage, which indicated that the use of a
tourniquet in TKA might hinder patients' early postopera-
tive exercises.
Regarding the complications, the results of this meta-
analysis confirm that there was a greater complication
incidence in tourniquet-assisted procedures.
During the operation, thrombosis is a common and po-
tentially fatal complication. Our result confirmed that
there was a greater incidence when a tourniquet was used
in TKA (RR = 5.00; P = 0.02). The finding of the current
study was similar to the result disclosed by Parmet et al.
that tourniquets used in patients were 5.33-fold greater
risk of having a large emboli compared with TKA without
a tourniquet [34]. There were also some strong evidences
that tourniquet group could lead to a higher risk of
thromboembolic events [31,32,35,36]. Our study indicated
that using a tourniquet in TKA might increase the mor-
bidity rate. The reasons are as follows: The formation of
thrombi is associated with the triad of venous stasis, endo-
thelial injury, and hypercoagulability, which is present
in patients being managed with TKA [37]. A tourni-
quet can cause venous stasis, endothelial damage via dir-
ect trauma, and possible damage to calcified blood vessels.
Zahavi et al. reported that ischemia from tourniquet use
increases levels of plasma beta-thrombolobulin and plasma
thromboxane-B2, thus increasing the risk of thrombosis
in patients undergoing TKA [38]. In addition, Katsumata
et al. found that during TKA, the use of a tourniquet
might promote the local release of neutrophil elastase
from the neutrophils together with reactive-oxygen deriv-
atives, which can contribute to the development of DVT,
PE, and tissue injury [39].
The complications were recorded in 13 RCTs. The
pooling data showed that the tourniquet group had a
greater risk of non-thrombotic complications compared
with the non-tourniquet group (RR = 2.03; P = .02). Our
finding was in accordance with the earlier published
studies [40,41]. Olivecrona et al. reported the tourniquet
time and cuff pressure were significantly associated with
an increased risk of complications after TKA [8,42,43].
The use of a tourniquet in TKA was identified as a risk
factor for the complications. The reasons are as follows:
Firstly, the direct pressure of a tourniquet damages the
nerves and local soft tissues [44]. Secondly, reactive
hyperemia and increased fibrinolytic activity occur after
tourniquet release increased the tissue pressure and local
inflammation leading to tissue hypoxia and subsequently
compromised wound healing [28,45]. Finally, the use of
a tourniquet tethers the quadriceps mechanism and thus
alters the intraoperative patellofemoral tracking. Then,
Figure 2 Forest plot for blood loss. (a) Intraoperative blood loss between TKA with a tourniquet and TKA without a tourniquet. (b) Postoperative
visible blood loss between TKA with a tourniquet and TKA without a tourniquet. (c) Calculated blood loss between TKA with a tourniquet and TKA
without a tourniquet. (d) Rate of transfusion between TKA with a tourniquet and TKA without a tourniquet. CI confidence interval, IV inverse variance.
Figure 3 Forest plot for operation time between TKA with a tourniquet and TKA without a tourniquet. CI confidence interval, IV inverse variance.
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Figure 4 Forest plot for postoperative knee ROM in early stage between TKA with/without a tourniquet. CI confidence interval, M-H
Mantel-Haenszel statistics.
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balancing and result in the unnecessary performance of
a lateral release [46], which might have a detrimental ef-
fect on patellar viability [47] and could increase the inci-
dence of hematomas requiring drainage and wound edge
avascularity [48].
This study revealed that the use of a tourniquet in
TKA was not associated with the total blood loss, which
is consistent with a previous meta-analysis [2]. Although
there is a contradictory meta-analysis about the effect of
a tourniquet on total blood loss following TKA [40],
some studies of this meta-analysis might had ignored
the hidden blood loss, when they calculated the overall
blood loss just by adding up the intraoperative blood
loss and postoperative visible blood loss together. Ac-
cording to the result of our study, using a tourniquet in
TKA decreased the intraoperative blood loss by 232.4 ml
compared to TKA without a tourniquet. There was
no significant difference in postoperative visible bloodFigure 5 Forest plot for thrombotic events and incidence of other co
plot for thrombotic events between TKA with a tourniquet and TKA withou
complications between TKA with a tourniquet and TKA without a tourniquloss and overall blood loss. Therefore, it can be expli-
citly deduced that TKA with a tourniquet could in-
crease postoperative hidden blood loss. The result of
the current study is consistent with Tetro et al.'s [5]
and Li et al.'s findings [24]. Sehat et al. reported that the
total blood loss included the visible blood loss and the
hidden blood loss, and what is more, the mean hidden
loss is 50% of the total blood loss [49]. The mechan-
ism of the hidden blood loss was generally accepted
as the residual blood into the joint and extravasations
into the tissue [50]. After the tourniquet was released,
the reactive blood flow reaches its peak within 5 min
[51] and postischemic reactive hyperemia reflects the
body's attempt to cleanse the limb of the metabolic prod-
ucts of anoxia and according for approximately one half of
the hidden blood loss [52]. Meanwhile, the increased fi-
brinolytic activity associated with tourniquet-induced is-
chemia promotes bleeding into the local tissues following
the procedure [27,53,54].mplications between TKA with/without a tourniquet. (a) Forest
t a tourniquet. (b) Forest plot for the incidence of the other
et. CI confidence interval, M-H Mantel-Haenszel statistics.
Table 2 Study characteristic
Study Sample size Total size Gender M/F ratio Mean age (years) BMI (kg/m2) Drain Tourniquet
duration
Anticoagulation
T NT T NT T NT T NT
Tai [21] 36 36 72 9/27 8/28 72.1 71.5 28.6 27.9 N Part None
Ledin [22] 25 23 48 10/15 9/14 70.0 71.0 29.0 28.0 Y Overall Heparin
Zhang [23] 30 30 60 8/22 11/19 72.0 71.0 25.0 26.0 Y Overall Heparin
Li [24] 40 40 80 11:29 3/13 71.0 70.0 27.3 26.8 N Part Heparin
Kageyama [25] 11 11 22 2/9 2/9 73 76.0 NS NS NS NS NS
Matziolis [26] 10 10 20 2/8 3/7 72.4 76.6 28.3 29.5 NS NS NS
Aglietti [27] 10 10 20 3/7 4/6 70.0 68.0 27.9 27.3 Y Part NS
Tetro [5] 33 30 63 15/18 11/19 69.8 69.8 NS NS Y Part Coumarins
Clarke [28] 20 10 30 NS NS NS NS NS NS Y NS NS
Wauke [29] 19 18 37 0/19 0/18 63.2 61.4 NS NS NS NS Heparin
Vandenbussche [30] 40 40 80 9/31 16/24 72.5 68.5 NS NS Y Overall Heparin
Wakankar [31] 37 40 77 11/26 14/26 72.5 71.8 NS NS Y NS Warfarin
Abdel-Salam [32] 40 40 80 17/23 15/25 72.0 74.0 NS NS Y Overall Heparin
T TKA with a tourniquet group, NT TKA without a tourniquet group, N no drainage system was used in TKA, Y drainage system was used in TKA, Part tourniquet
was not inflated during the entire operation, Overall tourniquet was inflated during the entire operation, NS not stated.
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overall blood loss and there was no significant difference
between the tourniquet group and non-tourniquet group
following the total blood loss.
Therefore, although the use of a tourniquet reduced the
intraoperative blood loss, it could not decrease the total
blood loss and the incidence of transfusion effectively.
For operation time, it mainly depends on the surgical
technique of the surgeons in the uncomplicated TKA.
This meta-analysis found that the operation time was
shorter in tourniquet group than that in the non-
tourniquet group. The application of a tourniquet in
TKA was believed to be effective for providing a relative
bloodless field, which facilitate saving surgical time. In
this current study, there were two RCTs that confirmed
that non-tourniquet resulted in less operation time
[2,55], whereas no significant difference was observed in
other six RCTs [5,22,25-27,29,30]. However, the pooling
result showed that TKA with a tourniquet could save
the operation time for only 4.57 min compared to TKA
without a tourniquet, which had no clinical significance.
For ROM, Forest plot showed that the postoperative
ROM in tourniquet group was 10.41° less than that in
non-tourniquet group in the early stage. The similar re-
sult recorded by Wakankar et al. showed 9.48° difference
in favor of TKA without tourniquet over TKA with a
tourniquet [31]. There were also several strong evidences
from other RCTs that non-tourniquet group resulted in
a better ROM [22,31,32]. Meanwhile, the result by Ledin
et al. showed the ROM was less in tourniquet group
than that in non-tourniquet group from 3 days to 2 years
post-operatively [22], which indicated that TKA with a
tourniquet might hamper patients' early postoperativeexercises. The mechanism behind the reduce ROM is not
very clear. The possible reasons are as follows: (1) Using a
tourniquet could injure the nerve and the skeletal muscle,
even causing rhabdomyolysis [56]. The delay in the nerve
conduction and the changes by electromyography of the
extensor apparatus have been recorded in tourniquet
group [7,57]. The result by Liu et al.'s trial showed that
non-tourniquet group could support more energy in their
quadriceps muscle than the tourniquet group [7]. (2) The
direct damage of the tourniquet and reperfusion injury
might increase pain that would reduce the patient's ability
to perform postoperative training [22]. (3) TKA with a
tourniquet could increase postoperative additional hidden
blood loss compared to TKA without a tourniquet. Then,
the additional hidden blood loss escapes into the joint
space and the soft tissue that would result in limb swelling
[50]. Additional swelling might produce an increased
weight in the affected limb sufficient to require more
muscle force for conducting straight-leg raising activities.
Meanwhile, it would also increase the tension of soft tis-
sues, which lead to oxygen tension decrease [55].
There is less blood in the operating field with a tourni-
quet, which theoretically is to achieve better cementa-
tion [40]. However, it is unknown at present if TKA
without a tourniquet could potentially lead to increased
component loosening over time [58]. Furthermore, the
good cement-bone interface shear strength during hip
arthroplasty is obtained [59]. The study by Ledin et al.
showed that there was no difference between the tourni-
quet group and the non-tourniquet group in migration,
which was measured by radiostereometric analysis in 2
years postoperation [22]. The current meta-analysis had
several strengths. First, all 13 included studies were
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quality; second, the total blood loss was calculated by
Gross formula [60], which is close to the actual situation;
third, there were many controversies in the effect of sim-
ultaneous and staged TKA [61]. Therefore, we excluded
the studies of bilateral TKA, which made the results
more precise.
The limitations of this analysis are the following:
Firstly, the study was limited to the literatures published
in English. Selection bias in language must have existed.
Secondly, there were some biases in these studies that
might come from the measurement of the total blood
loss of our study. The reason may be that the periopera-
tive blood loss in TKA patients was associated with not
only the application of tourniquet but also the other
perioperative management, such as the drain [62], anti-
coagulant therapy [63], and the timing of lower limb
tourniquet application [17,64] (Table 2).
Conclusions
This meta-analysis demonstrates that non-tourniquet use
in TKA has better clinical outcomes with regard to the in-
cidence of complications and ROM in early postoperative
period. There was no significant difference between the
two groups in the actual blood loss. Therefore, consider-
ing the effectiveness and safety of the use of a tourniquet
in TKA, the surgeons should use it prudently.
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